FDA Brief

Company record

Direct Rx

0 FDA warning letters since 2023 and 2 recalls in the last 12 months.

Get an email the day FDA posts anything new about Direct Rx.

Recalls

ReportedClassFirmProduct and reason
Nov 4 Class II Direct Rx
Drug
Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50
Subpotent Drug
Jul 1 Class II Direct Rx
Drug
DULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps; b) 30 mg (NDC 61919-482-60), 60 Caps; CYMBALTA, Packaged and Distributed by Direct Rx.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit